The drug regulators’ decision to take the low road and ban compounded weight loss drugs won’t help those suffering health complications from obesity.
There is a war over Ozempic at the moment. The players in this war are many and share one thing in common: their actions aren’t helping overweight Australians.
Loading...
Nick Coatsworth is a health reform advocate and doctoral scholar at the ANU School of Regulation and Governance.
